RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
This federal contract opportunity has been awarded to on September 28, 2026.
Award Information
This solicitation resulted in an award to for approximately $340,910,795 on September 28, 2026. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
- Award Number
- 75A50126C00010
- Award Amount
- $340,910,795
- Award Date
- September 28, 2026
Key Takeaways
- No response deadline specified - contact the agency for details
- Set-aside for No Set Aside businesses
- Work to be performed in WASHINGTON, DC
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- 75A50126C00010
- Opportunity Type
- Award Notice
- Sub-Agency
- OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Posted Date
- Wednesday, September 30, 2026
- Response Deadline
- Not specified
- PSC Code
- AB12
- Set-Aside
- No Set Aside
- Place of Performance
- WASHINGTON, DC, 20515
- Status
- Active
Description
This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in WASHINGTON, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
